SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

20 hedge funds and large institutions have $3.07M invested in Seelos Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$451K
2
+$74K
3
+$68K
4
WS
Wedbush Securities
California
+$60.7K
5
CH
CVI Holdings
Delaware
+$54K

Top Sellers

1
-$361K
2
-$31.8K
3
-$29K
4
Squarepoint
Squarepoint
New York
-$3.5K
5
PAM
Panagora Asset Management
Massachusetts
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$927K
2
$604K
3
$451K
4
$288K
5
$220K
6
$141K
7
$75K
8
$68K
9
$63K
10
$54K
11
$46K
12
$25K
13
$22K
14
$21K
15
$21K
16
$17K
17
$14K
18
$12K
19
$3K
20
$2K
21
–
22
–
23
–